Company: DAI – Fleming Fund

DAI – Fleming Fund is a prominent initiative in Pakistan focused on enhancing the country’s capacity to combat antimicrobial resistance (AMR). By collaborating with local governments, healthcare providers, and other stakeholders, the program aims to improve data collection and reporting on antibiotic usage and resistance patterns. Through capacity-building activities, the initiative seeks to establish effective surveillance systems and promote responsible antibiotic use, ultimately contributing to better public health outcomes in Pakistan.